The loss before income taxes for the first
quarter of 2009 was $2.7 million. The $2.7 million loss is primarily
attributable to a $1.5 million loss is recorded as part of litigation
and insurance charges, including $1.0 million in legal costs accrued to
defend intellectual property rights.
This compares to a loss before
income taxes for the first quarter of 2008 of $1.3 million. The company
was cash flow positive for the first quarter of 2009.
"We grew
our RA business at a healthy pace while dealing with the continued
negative impact of the economic downturn on hospital admissions and the
resulting diminished volume of surgical procedures,” says Donald M.
Earhart, chairman and CEO. “We delivered this solid performance by
finding better ways to serve customers and by focusing on our core
message – that the use of ON-Q to relieve post-surgical pain results in
a significant reduction in narcotics intake and significantly better
pain relief than narcotics alone.”